NJ SCR54 | 2022-2023 | Regular Session
Note: Carry Over of previous SCR107
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on January 31 2022 - 25% progression, died in committee
Action: 2022-01-31 - Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
Pending: Senate Health, Human Services and Senior Citizens Committee
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on January 31 2022 - 25% progression, died in committee
Action: 2022-01-31 - Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
Pending: Senate Health, Human Services and Senior Citizens Committee
Text: Latest bill text (Introduced) [HTML]
Summary
Urges U.S. President, Congress, and Department of Health and Human Services to ease patient limits applicable to private physicians prescribing buprenorphine as part of medication-assisted treatment for substance use disorders.
Title
Urges U.S. President, Congress, and Department of Health and Human Services to ease patient limits applicable to private physicians prescribing buprenorphine as part of medication-assisted treatment for substance use disorders.
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2022-01-31 | Senate | Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee |
Same As/Similar To
SCR107 (Carry Over) 2020-03-16 - Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
Subjects
New Jersey State Sources
| Type | Source |
|---|---|
| Summary | https://www.njleg.state.nj.us/bill-search/2022/SCR54 |
| Text | https://pub.njleg.gov/Bills/2022/SCR/54_I1.HTM |
